- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01863797
Trial on Early Induction Versus Expectant Management of Nulliparous Women With a Prolonged Latent Phase
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Stockholm, Sweden, 182 88
- Förlossningen, Danderyd Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- generally healthy nulliparous women and normal pregnancies (in vitro-fertilisation included)
- with a singleton fetus in cephalic presentation,
- gestational age between 37+0 and 41+6,
- continuous contractions exceeding 18 hours impeding rest (women's report),
- a cervical dilation of less than four centimetres and intact membranes. Gestational age was confirmed by ultrasound in the first trimester.
Women had to be able to read, understand and speak Swedish.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Early induction
Induction was performed if membranes were still intact and cervical dilation was less than four centimetres five hours after medication for therapeutic rest. For participants with an unripe cervix intravaginal prostaglandin E2 (PgE2, dinoproston) was used. A transcervical catheter (BARD) was inserted if this procedure was possible 19 and if cervical dilatation permitted, amniotomy was performed. The physician in charge performed all assessments and procedures except amniotomy. When the participants reached the active phase they were monitored according to the clinical guidelines. |
|
Experimental: expectant management
The participants in the control group awaited spontaneous onset of labour as long as possible (expectant management).
If contractions had ceased or subsided after the therapeutic rest women could be discharged from hospital, but were still included in the study.
When reaching the active phase of labour women were monitored according to the clinical guidelines.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The primary outcome was mode of delivery (caesarean sections and vaginal deliveries (spontaneous and instrumental))
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
|
Participants will be followed for the duration of hospital stay, an expected average of 3 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maternal outcome measure included experience of delivery
Time Frame: Experience of delivery was assessed two days after delivery
|
Wijma Delivery Experience Questionnaire - validated instrument.
The 33 question questionnaire was filled in by the participance two days after delivery at postnatal care unit or at home.
|
Experience of delivery was assessed two days after delivery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maternal outcome measures included duration of labour, labour analgesia, intrapartum exogenous oxytocin stimulation, partum haemorrhage, number of sphincter tears.
Time Frame: Duration of labour, labour analgesia, intrapartum exogenous oxytocin stimulation were measured from cervical dilatation of 4 cm until delivery. Post partum hemorrhage was measured two hours after delivery. Sphincter tear measure directly after delivery.
|
Duration of labour was measured in hours from cervical dilatation of four cm until delivery.
Only the most active analgesia was recorded during active delivery (from cervical dilatation of four cm until delivery).
Intrapartum exogenous oxytocin stimulation during active labour was recorded (yes or no).
Post partum hemorrhage was measured from delivery and until two hours after delivery.
|
Duration of labour, labour analgesia, intrapartum exogenous oxytocin stimulation were measured from cervical dilatation of 4 cm until delivery. Post partum hemorrhage was measured two hours after delivery. Sphincter tear measure directly after delivery.
|
Neonatal outcomes; birth presentation, Apgar score below 7 and cord artery metabolic acidosis, admission to neonatal intensive care (NICU), birth weight and child's head circumference
Time Frame: Neonatal outcomes were measured from delivery and until two days after delivery.
|
Birth presentation was assessed at delivery.
Apgar score was assessed five minutes after delivery and cord artery metabolic acidosis assessed at delivery.
Admission to NICU was measured from delivery and until two days after delivery.
Birth weight and child's head circumference was measured in average two hours after delivery.
|
Neonatal outcomes were measured from delivery and until two days after delivery.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- EPN 2007/65-31/2
- 2007/65-31/2 (Other Identifier: EPN Stockholm)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Early induction
-
University of ValenciaCompletedHappiness | SadnessSpain
-
Centre Hospitalier Universitaire, AmiensUniversité de LilleCompletedChronic Pain | Fibromyalgia | Rumination | Repetitive Negative ThinkingFrance
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedEndothelial Dysfunction | EmotionsUnited States
-
Universidad de LeónCompletedFoot Diseases | Myofascial PainSpain
-
Foundation University IslamabadRecruitingHypertrophic ScarPakistan
-
University of DenverWake Forest UniversityCompleted
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedAngioplasty PatientsUnited States
-
University of KonstanzJimma UniversityCompleted
-
The Second Affiliated Hospital of Dalian Medical...CompletedAdverse EffectsChina